Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

635 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin.
Jonas S, Rayes N, Neumann U, Neuhaus R, Bechstein WO, Guckelberger O, Tullius SG, Serke S, Neuhaus P. Jonas S, et al. Cancer. 1997 Sep 15;80(6):1141-50. doi: 10.1002/(sici)1097-0142(19970915)80:6<1141::aid-cncr18>3.0.co;2-8. Cancer. 1997. PMID: 9305716 Clinical Trial.
Conversion to tacrolimus after liver transplantation.
Jonas S, Bechstein WO, Lemmens HP, Kling N, Grauhan O, Lobeck H, Neuhaus P. Jonas S, et al. Transpl Int. 1996;9(1):23-31. doi: 10.1007/BF00336808. Transpl Int. 1996. PMID: 8748407 Clinical Trial.
Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized study.
Langrehr JM, Guckelberger O, Nüssler N, Radtke A, Lemmens HP, Jonas S, Lohmann R, Tullius S, Steinmüller T, Raakow R, Neumann U, Knoop M, Bechstein WO, Neuhaus P. Langrehr JM, et al. Among authors: jonas s. Transplant Proc. 1996 Dec;28(6):3204. Transplant Proc. 1996. PMID: 8962241 Clinical Trial. No abstract available.
A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppressive induction therapy following orthotopic liver transplantation.
Langrehr JM, Nüssler NC, Neumann U, Guckelberger O, Lohmann R, Radtke A, Jonas S, Klupp J, Steinmüller T, Lobeck H, Meuer S, Schlag H, Lemmens HP, Knoop M, Keck H, Bechstein WO, Neuhaus P. Langrehr JM, et al. Among authors: jonas s. Transplantation. 1997 Jun 27;63(12):1772-81. doi: 10.1097/00007890-199706270-00012. Transplantation. 1997. PMID: 9210503 Clinical Trial.
635 results